Vital Neuro

Vital Neuro

Created using Figma
Vital Neuro, Inc.는 초기 주식 매입 ( "ICO")을 시작했습니다. ICO는 자본 투자 및 배당 기회가있는 투자자에게 암호 침해를 제공합니다. Vital Neuro는 클라우드 기반 치료 시스템을 개발했습니다. 클라우드 기반 스토리지는 스마트하고 사용하기 쉬운 헤드폰과 함께 제공됩니다. 우리는 현재 집중력을 높이고 스트레스 및 스트레스와의 싸움을 줄이기 위해 고안된 최종 신청서입니다. 회사는 건강한 B2B 솔루션을 갖추고 있으며 정신 건강 치료의 현재 상태를 바꿀 수 있습니다.
ICO
2018. 7. 14.
2019. 3. 31.
100% 완료된
$19 998
0% 단단한 모자 완료된
단단한 모자 49 750 000.00 USD
past
기업 세부 정보
등록 된 국가
United States
추가 세부 사항
카테고리
플랫폼

약 Vital Neuro

Vital Neuro’s innovative science-based platform offers a solution to these issues through stress reduction as a service. A Mobile SaaS for enterprise customers where employers provide their team members with enjoyable, neuroscience-based stress reduction sessions built on real time monitoring of personal biosignals. The results… improved job satisfaction, higher productivity, lower employee turnover, and increased EBITDA.

Science Journalist and New York Times Bestselling Author Max Lugavere sits down with Vital Neuro Founder & Chief Product Officer Alex Doman. These friends catch up on what’s been happening behind the scenes at Vital with the development of Leonardo, a neuroscience-based mobile smart cloud solution which easily and effectively reduces workplace stress.

Vital Neuro’s innovative science-based platform offers a solution to these issues through stress reduction as a service. A Mobile SaaS for enterprise customers where employers provide their team members with enjoyable, neuroscience-based stress reduction sessions built on real time monitoring of personal biosignals. The results… improved job satisfaction, higher productivity, lower employee turnover, and increased EBITDA.  

% name % 로드맵

  • Q1 2016

  • ABT & BRC founders Alex Doman and Kamran Fallahpour, PhD. join forces to start Vital Neuro to bring cloud based scientific stress relief to the market.
  • Q2 2016

  • Founded Vital Neuro, Inc., produced and demonstrated working model of wired, in lab service,
    and added Q Saeed as co-founder and CEO.
  • Q3 2016

  • Founders develop Enterprise Go-to-market strategy, funding path and model, and transition plan to
    on-board from ABT and BRC to Vital. Specifications for initial smart headphone with integrated EEG
    sensors begin.
  • Q4 2016

  • ABT & BRC contribute IP and know how to Vital as royalty free, perpetual licenses. End to end cloud
    system architecture and app to enable the Vital prototype initiated.
  • 더 읽기
  • Q1 2017

  • Prototype service budgeted including Vital smart cloud system Leonardo, resident machine learning
    engine, and 1st wireless sensors. Bruce Clay joins team to aid on Corporate Development, LOI secured
    from a targeted BPO for a pilot.
  • Q2 2017

  • Sourcing and hiring for MVP in process, Delivered ver. 1 & 2 of smart headphone, began MVP app &
    cloud integration. Initial commercial headphone design completed.
  • Q3 2017

  • Closed $675,000 Reg D Private Sale Non-Token Equity Round to fund prototype development. Lead
    investor Bruce Clay joins BoD, and executive team as co-founder.
  • Q4 2017

  • Prototype iOS app & cloud service completed. 2nd generation miniaturized wireless EEG board completed.
  • Q1 2018

  • Completing cloud & app development, and wireless smart headphone prototype. Dry EEG sensor testing and selection complete.
  • Q2 2018

  • Admin dashboard, app, and Leonardo smart cloud refinement for MVP. MVP completion and UAT initiated.
  • Q3 2018

  • Complete UAT. Launch ICO via Neuros Token, Inc. to complete products, launch pilots, manufacturing, sales and go to market.

행사 참여

Vital Neuro 팀

검증 됨 0%

주의. 확인되지 않은 회원은 실제로 팀원이 아닌 위험이 있습니다.

Q Saeed
Founder & CEO
확인되지 않음
Kamran Fallahpour
Founder & CSO
확인되지 않음
Alex Doman
Founder & CPO
확인되지 않음
Bruce J. Clay
Founder & EVP of Finance and Corporate Development
확인되지 않음

Vital Neuro 최근 뉴스

  • 정보 업데이트에는 시간차가있을 수 있으므로 각 ICO 프로젝트에 대한 정확한 정보는 공식 웹 사이트 또는 기타 커뮤니케이션 채널을 통해 확인해야합니다.
  • 이 정보는 ICO 기금 투자에 대한 제안이나 조언이 아닙니다. 관련 정보를 철저히 조사하고 ICO 참여를 결정하십시오.
  • 이 콘텐츠에 대해 수정해야 할 문제 또는 문제가 있다고 생각되거나 자신의 ICO 프로젝트를 제출하고자 할 경우 이메일을 보내주십시오. a>
면책 조항 및 위험 경고를 읽으십시오. 면책 조항 및 위험 경고 표시.